Table 2 Relationship between the eligibility criteria and tumor response (n = 85).

From: Prognostic impact of clinical trial eligibility in patients with advanced gastric cancer

 

Tumor response, n (%)

P value

CR

PR

SD

PD

Eligible group (n = 41)

2 (4.9)

21 (51.2)

10 (24.4)

8 (19.5)

< 0.01

Ineligible group (n = 44)

1 (2.3)

12 (27.3)

5 (11.4)

26 (59.1)

 
  1. CR complete response, PR partial response, SD stable disease, PD progressive disease
Back to article page